This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://dx.doi.org/10.1097/
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q69819617

rdf:type

wikibase:Item

schema:description

artikull shkencor i botuar më 01 shkurt 1988 наукова стаття, опублікована в лютому 1988 scientific article published on 01 February 1988 im Februar 1988 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu espublizáu en febreru de 1988

p:P577

wds:Q69819617-DD30832F-7E84-4D82-B89F-BC305B189D8D

wdt:P577

1988-02-01T00:00:00Z

p:P407

wds:Q69819617-F61C626A-2D70-4411-8986-AD17D38203C2

wdt:P407

wd:Q1860

p:P2093

wds:Q69819617-3ADCDB39-353B-4547-9582-4241EF574A97 wds:Q69819617-295F3E9A-9FF1-44EC-B838-B7BEC9256601 wds:Q69819617-B10BE534-047C-41FF-BD71-D7530B164ACB wds:Q69819617-7BDBB7A5-A8B2-447E-A1B2-AEE0F31092A3 wds:Q69819617-FCA3AF8E-B058-4DD2-9A5A-7905A56672B5 wds:Q69819617-D1EE9E94-06D3-4842-B1ED-8A0D91C2CB9B wds:Q69819617-C47A7EC2-002E-4AE3-ACF2-C5FA5143F639

wdt:P2093

H Graf G Mayer E Pohanka O Traindl J Smolen M Schwarz J Kovarik

rdfs:label

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

skos:prefLabel

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

schema:name

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

p:P1476

wds:Q69819617-940D6462-4B08-4B61-B047-0D736225B416

wdt:P1476

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

p:P304

wds:Q69819617-E1DEE12E-7C56-47AA-9995-AE14A231AC19

wdt:P304

402-405

p:P31

wds:Q69819617-5BBE34C0-51F5-4880-BFD3-7DDE245A158D

wdt:P31

wd:Q13442814

p:P921

wds:Q69819617-C6D04168-C14B-4989-B73F-105C9D7CD0A0

wdt:P921

wd:Q2076966

p:P698

wds:Q69819617-EB0CC056-5089-469B-BC0B-789A79B77A0B

wdtn:P698

n10:2830688

wdt:P698

2830688

p:P1433

wds:Q69819617-FEDA5D34-6A9E-4B92-B9AF-0B2483299ACE

wdt:P1433

wd:Q15730500

p:P433

wds:Q69819617-D2AF57C1-CA91-4E6F-92BB-BDB8A6A02235

p:P478

wds:Q69819617-47ED7AEA-389F-45C4-9778-9FF3EC78434C

wdt:P433

2

wdt:P478

45

p:P356

wds:Q69819617-147F6FE7-E290-4E9F-BBE6-5D61D91F15FC

wdtn:P356

n12:00007890-198802000-00031

wdt:P356

10.1097/00007890-198802000-00031